The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Dyne Therapeutics Inc shares valued at $471,636 were sold by Kersten Dirk on Oct 18 ’24. At $35.16 per share, Kersten Dirk sold 13,414 shares. The insider’s holdings dropped to 73,225 shares worth approximately $2.37 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Kersten Dirk sold 121 shares, netting a total of over 4,242 in proceeds. Following the sale of shares at $35.06 each, the insider now holds 73,104 shares.
Before that, Kersten Dirk had sold 23,671 shares from its account. In a trade valued at $836,770, the Director traded Dyne Therapeutics Inc shares for $35.35 each. Upon closing the transaction, the insider’s holdings decreased to 23,671 shares, worth approximately $3.22 million.
As published in a research note from Chardan Capital Markets on May 21, 2024, Dyne Therapeutics Inc [DYN] has been retained to a Buy and the price target has been revised to $42. Analysts at Morgan Stanley started covering the stock with ‘”an Overweight”‘ outlook in a report released in late April. As of February 20, 2024, H.C. Wainwright has initiated its “Buy” rating for DYN. Earlier on February 27, 2023, Raymond James upgraded its rating. Their new recommendation was “a Strong buy” for DYN stock which previously was a “an Outperform”.
Analyzing DYN Stock Performance
During the last five days, there has been a drop of approximately -8.59%. Over the course of the year, Dyne Therapeutics Inc shares have jumped approximately 143.31%. Shares of the company reached a 52-week high of $47.45 on 08/20/24 and a 52-week low of $12.33 on 01/03/24. A 50-day SMA is recorded $36.88, while a 200-day SMA reached $31.23. Nevertheless, trading volume fell to 0.78 million shares from 0.71 million shares the previous day.
Support And Resistance Levels for Dyne Therapeutics Inc (DYN)
According to the 24-hour chart, there is a support level at 31.77, which, if violated, would cause prices to drop to 31.17. In the upper region, resistance lies at 33.19. The next price resistance is at 34.02. RSI (Relative Strength Index) is 41.97 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.29, which suggests the price will decrease in the coming days. Percent R is at 75.97%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
